425: Strive, Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. have announced a proposed business combination, with Strive filing a Form 425 communication regarding the transaction.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on October 2, 2025.
• The transaction involves Strive issuing additional shares of its Class A common stock, which may cause dilution.
• The companies anticipate strategic and financial benefits from the proposed transaction, including successful integration of combined businesses.
• Both companies acknowledge inherent risks and uncertainties associated with forward-looking statements regarding the merger.

Sentiment

Score: 6

Explanation: The filing announces a proposed merger, which is generally a positive strategic move, and highlights anticipated strategic and financial benefits. However, it also includes extensive and detailed disclosures of potential risks and challenges, balancing the overall sentiment towards neutral to slightly positive.

Positives

• Anticipated strategic benefits from the proposed transaction.
• Expected financial benefits from the proposed transaction.
• Belief in the ability to successfully integrate the combined businesses.

Negatives

• Potential for the integration of the two companies to be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with Bitcoin and other digital assets, and changes in or problems arising from implementation of Bitcoin treasury strategies.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock.
• Potential adverse reactions of customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors that could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The companies express expectations regarding the proposed transaction's strategic and financial benefits, its impact on the combined company's future financial performance, the timing of closing, and the ability to successfully integrate the businesses. These are forward-looking statements subject to various risks and uncertainties.

Management Comments

• Management of Strive and Semler Scientific hold opinions and judgments about future events related to the proposed transaction.
• Both Strive and Semler Scientific believe their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of existing knowledge of their business and operations.

Industry Context

The mention of 'implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates that at least one of the companies, or the combined entity, is engaging with or considering digital assets as part of its corporate treasury strategy. This reflects a growing trend among some public companies to diversify treasury holdings into cryptocurrencies, a move that can introduce new financial and regulatory risks.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is listed as a risk factor for the proposed transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement in connection with its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Shareholders of Semler Scientific will be asked to approve the proposed transaction.
• Customers and employees of both companies may have adverse reactions or changes to business or employee relationships as a result of the announcement or completion of the transaction.
• Management's attention may be diverted from ongoing business operations and opportunities due to the merger process.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock for the transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin Treasury Strategy, Corporate Governance